Summary
The electrophysiological effects of xamoterol were studied in ten patients with suspected coronary artery disease by intracardiac electrography. Sino-atrial and atrioventricular conduction times were both slightly shortened by 0.1 mg/kg of xamoterol. The atrioventricular nodal refractory periods were shortened without consistent change in atrial refractoriness. This dose raised mean blood pressure by only 3 mmHg and resting heart rate by only 4 beats/min. The effects suggest a beta1 agonist activity closer to that of prenalterol than that of pindolol under conditions of rest.
References
Pouleur H, Rousseau MF, Mengeot P, Veriter C, Vincent MF, Brasseur LA (1982) Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new Beta1-adrenoceptor partial agonist, ICI 118 587. Eur Heart J 3: 123–127
Rousseau MF, Pouleur H, Vincent MF (1983) Effects of a cardioselective Beta1 partial agonist (Corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction. Am J Cardiol 51: 1267–1274
Detry JMR, Decoster PM, Buy JJ, Rousseau MF, Brasseur LA (1984) Antianginal effects of Corwin, a new beta-adrenoceptor partial agonist. Am J Cardiol 53: 439–443
Nuttall A, Snow HM (1982) The Cardiovascular effects of ICI 118 587: A β1-adrenoceptor partial agonist. Br J Pharmacol 77: 381–388
Marlow HF, Wardleworth AG, Booth LM (1982) The haemodynamic effects of oral doses of ICI 118 587, a β-adrenoceptor partial agonist in healthy volunteers. Br J Clin Pharmacol 13: 269p-270p
Robinson C, Birkhead J, Crook B, Jennings K, Jewitt D (1978) Clinical electrophysiological effects of atenolol — a new cardioselective betablocking agent. Br Heart J 40: 14–21
Seides SF, Josephson ME, Batsford WP, Weisfogel GM, Lau SH, Damato AN (1974) The electrophysiology of propranolol in man. Am Heart J 88: 733–741
Berkowitz WD, Wit AL, Lau SH, Steiner C, Damato AN (1969) The effects of propranolol on cardiac conduction. Circulation 40: 835–862
Rizzon P, Di Biase M, Chiddo A, Mastrangelo D, Sorgente L (1978) Electrophysiological properties of intravenous metoprolol in man. Br Heart J 40: 650–655
Marchlinski FE, Buxton AE, Waxman HL, Josephson ME (1984) Electrophysiologic effects of intravenous metoprolol. Am Heart J 107: 1125–1131
Hombach V, Braun V, Hopp HW, Gil-Sanchez D, Behrenbeck DW, Tauchert M, Hilger HH (1982) Electrophysiological effects of cardioselective and non-cardioselective β-adrenoceptor blockers with and without ISA at rest and during exercise. Br J Clin Pharmacol 13: 285s-293s
Capucci A, Frabetti L, Melandri G, Magnani B (1983) Electrophysiologic properties of prenalterol. International J Cardiol 2: 391–400
Barlow JJ, Main BG, Snow HM (1981) β-Adrenoceptor stimulant properties of amidoalkylamino-substituted 1-aryl-2-ethanols and 1-(aryloxy)-2-propanols. J Med Chem 24: 315–322
Jennings G, Bobik A, Oddie C, Restall R (1984) Cardioselectivity, kinetics, haemodynamics, and metabolic effects of xamoterol. Clin Pharmacol Ther 35: 594–603
Harley A, Coverdale HA (1981) The electrophysiological effects of intravenous labetalol in man. Eur J Clin Pharmacol 20: 241–244
Ikaheimo MJ, Jakkunen JT (1964) The effects of beta1-adrenoceptor partial agonist ICI 118 587 on left ventricular function in patients with coronary heart disease. International J Cardiol 5: 339–349
Mason JW, Winkle M, Meffin PJ, Harrison DC (1978) Electrophysiological effects of acebutolol. Br Heart J 40: 35–40
Vargas G, Akhtar M, Damato AN (1975) Electrophysiological effects of isoproterenol on cardiac conduction system in man. Am Heart J 90: 25–34
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bowes, R.J., Gautam, P.C., Graham, D.R. et al. The electrophysiological effects of intravenous xamoterol in man. Eur J Clin Pharmacol 29, 731–734 (1986). https://doi.org/10.1007/BF00615969
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00615969